UltiMed Expands Syringe Portfolio with Launch of UltiCare® VetRx General Syringes

Audio By Carbonatix

EXCELSIOR, Minn.--(BUSINESS WIRE)--Sep 30, 2025--

UltiMed, Inc., the maker of the #1 vet-recommended insulin syringe, is proud to announce the launch of UltiCare ® VetRx General Syringes —a new line of high-performance syringes developed to meet the diverse daily injection needs of today’s veterinary clinics.

Available in a wide range of sizes and configurations—including both soft pack and hard pack formats —UltiCare ® VetRx General Syringes are engineered with the same precision, performance, and attention to detail that has made UltiCare a trusted name in veterinary diabetes care.

“This product expansion is a natural next step for UltiMed,” said Jim Erickson, President and CEO of UltiMed. “We’ve earned the trust of veterinarians nationwide with our insulin syringes. Now, we’re bringing that same commitment to quality and reliability to a full line of general-use syringes, helping clinics simplify sourcing without compromising performance.”

Product Features and Options Include:

• Multiple sizes and syringe types, including syringe-only and syringe-with-needle combinations
• Tuberculin low-dead space options for reduced waste and more efficient dosing
• Luer Lock and Luer Slip styles available in various sizes for secure connections
• Clear barrels with bold markings for accurate dosing
• Individually packaged for sterility and convenience

Manufactured in South Korea using advanced technology and rigorous quality controls, UltiCare ® VetRx General Syringes are backed by a reliable supply chain that ensures product availability when clinics need it most.

“Veterinary teams are stretched thin—especially when it comes to managing medical supply needs,” added Erickson. “We designed this new line to offer peace of mind with consistent quality, flexible formats, and dependable delivery.”

With this expansion, UltiMed strengthens its position as a one-stop solution for veterinary medication delivery, offering a comprehensive portfolio that now includes both insulin and general-use syringes.

Veterinarians and clinic buyers can learn more or request samples by visiting info.ultimedinc.com/syringes.

About UltiMed, Inc.

Founded in 1988, UltiMed, Inc. offers a comprehensive portfolio of innovative medication delivery devices for human and veterinary use. From pen needles and insulin syringes to pet glucose monitoring systems, UltiMed is dedicated to improving safety, convenience, and access across the healthcare spectrum. Learn more at www.ultimedinc.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250926198418/en/

CONTACT: Media Contact:

Ann Heinle

Senior Marketing Manager

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA MINNESOTA

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES CONSUMER DIABETES OTHER HEALTH PETS VETERINARY

SOURCE: UltiMed, Inc.

Copyright Business Wire 2025.

PUB: 09/30/2025 09:00 AM/DISC: 09/30/2025 08:59 AM

http://www.businesswire.com/news/home/20250926198418/en